Laponis Adam 4

What Happened
Adam Laponis, Chief Financial Officer of Twist Bioscience (TWST), sold 7,000 shares on February 12, 2026, at $50.00 per share for total proceeds of $350,000. This was a sale (disposition) rather than a purchase or option exercise.

Key Details

• Transaction date and price: 2026-02-12 — 7,000 shares at $50.00 each.
• Total proceeds: $350,000.
• Shares owned after transaction: Not specified in the information provided on this Form 4.
• Footnote: Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025.
• Filing timeliness: Report filed 2026-02-13 for a 2026-02-12 transaction (appears timely).

Context
Sales under 10b5-1 plans are pre-scheduled and are common for insiders to meet liquidity goals or diversify holdings; they do not necessarily indicate a change in view on the company. For retail investors, purchases typically carry more signal value than routine sales, but tracking insider activity alongside fundamentals and other news can be useful.